Passa al contenutoPassa al piè di pagina
      employer cover photo
      employer logo
      employer logo

      PathologyWatch

      Questa è la tua azienda?

      Recensioni su PathologyWatch

      Not a long term gig - Recensione dipendente - Technician presso PathologyWatch

      2,0
      20 nov 2022
      Technician
      Consiglia
      Gradimento del CEO
      Pronostico commerciale

      Vantaggi

      Free food and snacks! Pay is okay. Most people are friendly.

      Svantaggi

      I think it is a good company with alot of potential but the management here really need help. Can't quite figure out who is in charge. Is it the lead techs, VP, director, or the manager. Very confusing. Sooooo many changes that do not make sense and create so much more work. Don't think this would be a long term job for anyone. Lot of people before me. Seems to be quite a few errors that are not caught in the lab. There are days of total chaos and no one seems to be able to figure out what is going on or what needs to be done.

      Esplora altre recensioni su PathologyWatch

      5,0
      3 feb 2023
      C-suite executive
      Consiglia
      Gradimento del CEO
      Pronostico commerciale

      Vantaggi

      Good environment. People work together. Off-site meeting was good this year (2022). Benefits have improved over my time here and are quite decent for a small company.

      Svantaggi

      Have to work hard. A lot of us pull a lot of hours. Not necessarily a bad thing, just something to be aware of.

      2,0
      15 nov 2021
      Vice president of engineering
      Consiglia
      Gradimento del CEO
      Pronostico commerciale

      Vantaggi

      Interesting business with possibly large impact.

      Svantaggi

      I'm concerned about the profile of the founders and the priorities of the organization being built. I'm concerned about their approach to legal & regulatory compliance (or lack thereof). This business will directly affect patient safety and outcomes, and I worry that the team is not adequately working to manage the promises that have been made. I'm concerned that the company is regularly prioritizing growth over patient safety, with general recommendations coming from leadership that recommended cutting corners and avoiding the hard problems that need to be worked on. This shouldn't be a growing pain, but perhaps that's all that it will be. I believe that the company may succeed in spite of my concerns and that things can improve.

      Vedi recensioni per: Utile|Valutazione|Data|Tutto
      Ricerche correlate: Offerte di lavoro di PathologyWatch | Stipendi di PathologyWatch | Benefit di PathologyWatch | Colloqui di PathologyWatch
      Recensioni su PathologyWatchRecensioni per Technician presso PathologyWatchRecensione su PathologyWatch